Also known as: Serrapeptase / Serralysin
Serratiopeptidase (Serrapeptase) is a serine proteolytic enzyme derived from the non-pathogenic enterobacteria Serratia E15. It exhibits potent anti-inflammatory, analgesic, and fibrinolytic properties by breaking down dead or damaged tissue, fibrin, and other proteins involved in inflammation. Widely used in post-surgical care, ENT conditions, and musculoskeletal disorders. Mediocon Inc manufactures high-activity Serratiopeptidase API at its GMP facility.
| Parameter | Specification |
|---|---|
| CAS Number | 129580-63-8 |
| Molecular Formula | Complex enzyme (metalloprotease) |
| Molecular Weight | ~50,000 Da |
| Grade | IP / BP / EP / USP |
| Category | Anti-inflammatory / Proteolytic Enzyme |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Mfg Date | MAR 2025 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Serratiopeptidase — CAS 129580-63-8 (CAS 129580-63-8) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Serratiopeptidase — CAS 129580-63-8 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance